Молекулярная патология хромосомного района 10q23.3-26.3 при глиобластоме
Аннотация
Об авторах
Е. А. АлексееваРоссия
А. С. Танас
Россия
Е. В. Прозоренко
Россия
А. М. Зайцев
Россия
М. И. Куржупов
Россия
О. Н. Кирсанова
Россия
В. В. Руденко
Россия
Д. В. Залетаев
Россия
В. В. Стрельников
Россия
Список литературы
1. Dunn GP, Rinne ML, Wykosky J et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012;26(8):756-784.
2. Hutter A. Overview of Primary Brain Tumors: Pathologic Classification, Epidemiology, Molecular Biology, and Prognostic Markers. Hematol Oncol Clin North Am. 2012 Aug;26(4):715-732.
3. Jesionek-Kupnicka D, Szybka M, Potemski P et al. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Pol J Pathol. 2013 Dec;64(4):168-275.
4. Mizoguchi M, Kuga D, Guan Y et al. Loss of heterozygosity analysis in malignant gliomas. Brain Tumor Pathol. 2011 Jul; 28(3):191-196.
5. Ohgaki H, Kleihues P. Genetic Pathways to Primary and Secondary Glioblastoma. Am J Pathol. 2007 May;170(5):1445-1453.
6. Balesaria S, Brock C, Bower M et al. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer. 1999 Dec;81(8):1371-1377.
7. Tada K, Shiraishi S, Kamiryo T. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: Correlation with patients age and survival. J. Neuroserg. 2001 Oct;95(4):651-659.
8. Crespo I, Tao H, Nieto AB et al. Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels. PLoS One. 2012 Sep;7(9):e46088.
9. Heroux MS, Chesnik MA, Halligan BD et al. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. Physiol Genomics. 2014 Jul 1;46(13):467-481.
10. Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012 Dec;138(12):1971-1981.
11. Yang Y., Shao N, Luo G et al. Mutations of PTEN Gene in Gliomas Correlate to Tumor Differentiation and Short-term Survival Rate. Anticancer Res. 2010 Mar;30(3):P. 981-985.
12. Katoh M, Nakagama H. FGF Receptors: Cancer Biology and Therapeutics // Med Res Rev. 2014 Mar;34(2):280-300.
13. Nakahara Y, Shiraishi T, Okamoto H et al. Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization. Neuro-Oncology. 2004 Oct;6(4):281-289.
14. Ader I, Delmas C, Skuli N et al. Preclinical evidence that SSR128129E - A novel small-molecule multi-fibroblast growth factor receptor blocker - Radiosensitises human glioblastoma. Eur J Cancer. 2014 Sep;50(13):2351-2359.
15. Arshad H, Ahmad Z, Hasan SH. Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev. 2010;11(6):1637-1640.
16. Hegi ME, Liu L, Herman JG et al. Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity. J Clin Oncol. 2008 Sep 1;26(25):4189-4199.
17. Стрельников ВВ, Малышева АС, Шубина МВ и др. Делеции области расположения гена MGMT на хромосоме 10q26.3. Молекулярная медицина. 2011;(2):28-31.
18. Ginzinger DG, Godfrey TE, Nigro J et al. Measurement of DNA Copy Number at Microsatellite Loci Using Quantitative PCR Analysis. Cancer Res. 2000 Oct;60(19):5405-5409.
19. Nigro JM, Takahashi MA, Ginzinger DG et al. Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay. Am J Pathol. 2001 Apr;158(4):1253-1262.
20. Алексеева Е.А., Танас А.С., Прозоренко Е.В. и др. Анализ аллельного дисбаланса при глиобластоме: новые хромосомные участки потери гетерозиготности и новые гены-кандидаты. Медицинская генетика. 2014;(11):41-46.
21. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 1971 Apr.;68(4): 820-823.
22. Yin D, Ogawa S, Kawamata N et al. High Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray.Mol. Cancer Res. 2009 May; 7(5): 665-677.
Для цитирования:
Алексеева Е.А., Танас А.С., Прозоренко Е.В., Зайцев А.М., Куржупов М.И., Кирсанова О.Н., Руденко В.В., Залетаев Д.В., Стрельников В.В. Молекулярная патология хромосомного района 10q23.3-26.3 при глиобластоме. Медицинская генетика. 2016;15(12):14-22.
For citation:
Alekseeva E.A., Thanas A.S., Prozorenko E.V., Zaytsev A.M., Kurzhupov M.I., Kirsanova O.N., Rudenko V.V., Zaletaev D.V., Strelnikov V.V. Molecular pathology of the 10q23.3-26.3 chromosome region in glioblastoma. Medical Genetics. 2016;15(12):14-22. (In Russ.)